Related Experiment Video
Updated: Jun 1, 2026

Applying Advanced In Vitro Culturing Technology to Study the Human Gut Microbiota
Published on: February 15, 2019
Comparative Study of Prebiotics for Infants Using a Fecal Culture System: Insights into Responders and Non-Responders
Shijir Xijier Mingat1, Tatsuya Ehara1, Hirohiko Nakamura1
1Health Care & Nutritional Science Institute, R&D Division, Morinaga Milk Industry Co., Ltd., 5-1-83, Higashihara, Zama 252-8583, Japan.
Insights
A combination of lactulose, raffinose, and galactooligosaccharides (GOS) effectively promotes infant-type human-residential bifidobacteria (HRB) growth in infant gut microbiota. This blend supports a healthy gut microbiome, similar to breastfed infants.
Area of Science:
- Microbiology
- Nutritional Science
- Pediatrics
Background:
- Infant gut microbiota is crucial for health and dominated by bifidobacteria.
- Current infant formulas may not fully support the development of a healthy infant gut microbiome.
- Developing formulas that promote bifidobacteria is essential for infant health.
Purpose of the Study:
- To identify prebiotic oligosaccharides that promote the growth of all infant-type human-residential bifidobacteria (HRB).
- To find a prebiotic combination that minimizes non-responders in infant fecal cultures.
- To inform the development of infant formulas mimicking breastfed microbiota.
Main Methods:
- Utilized an infant fecal culture system to test various prebiotic oligosaccharides and their combinations.
- Assessed the growth-promoting effects of lactulose (LAC), raffinose (RAF), galactooligosaccharides (GOS), and fructooligosaccharides.
- Cultured samples from seven infants (1.5-10.2 months) with individual or combined oligosaccharides.
Main Results:
- No single oligosaccharide supported all infant-type HRB; GOS promoted most, excluding *Bifidobacterium longum* subsp. *longum*.
- The combination of LAC/RAF/GOS demonstrated even and effective promotion of all tested infant-type HRB.
- Acetate production was highest with GOS or LAC/RAF/GOS, indicating superior efficacy and fewer non-responders.
Conclusions:
- The LAC/RAF/GOS combination is a promising strategy for promoting a bifidobacteria-rich infant gut microbiota.
- This finding can guide the formulation of infant formulas to better support infant gut health.
- Aligning formula-fed infant gut microbiota with that of breastfed infants is achievable with targeted prebiotic interventions.
Background:
The gut microbiota of breast-fed infants is dominated by infant-type human-residential bifidobacteria (HRB) that contribute to infant health; thus, it is crucial to develop infant formulas that promote the establishment of a gut microbiota enriched with infant-type HRB, closely resembling that of breastfed infants.
Methods:
We compared various non-digestible prebiotic oligosaccharides and their combinations using a fecal culture system to explore which candidates could promote the growth of all infant-type HRB and rarely yield non-responders. The analysis included lactulose (LAC), raffinose (RAF), galactooligosaccharides (GOS), and short- and long-chain fructooligosaccharides. Fecal samples were collected from seven infants aged 1.5-10.2 months and cultured with each oligosaccharide individually or their combinations.
Results:
No single oligosaccharide effectively promoted the growth of all infant-type HRB, although GOS promoted the growth of HRB other than Bifidobacterium longum subsp. longum. Only the LAC/RAF/GOS group evenly and effectively promoted the growth of all infant-type HRB. Accordingly, acetate production was higher in fecal cultures supplemented with GOS or LAC/RAF/GOS than in the other cultures, suggesting that it is a superior combination for all infant-type HRB and rarely yields non-responders.
Conclusions:
This study can aid in developing infant formulas that help align the gut microbiota of formula-fed infants with that of breastfed infants.
Related Concept Videos
Sputum Studies II: Culture and Sensitivity
Sputum culture and sensitivity is a medical procedure used to diagnose bacterial infections in the respiratory tract and select the most appropriate antibiotics for treatment. This process involves analyzing sputum samples of thick and opaque secretions produced in the lungs and airways. These samples are collected from patients and then sent to the laboratory for analysis.
The test can identify various pathogens responsible for respiratory infections, including Streptococcus,...
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the colonic...
Urine Studies II: Urine Culture and Sensitivity Test
Probiotics
Development of Human Microbiota
Microbiota Modulation by Antibiotics

